Royalty Pharma plc - Class A — Quarterly Cash Flow (NASDAQ:RPRX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 18.22 B17.61 B18.32 B19.35 B19.62 B Total liabilities 7.88 B7.82 B8.82 B9.73 B9.91 B Total equity 10.34 B9.79 B9.5 B9.62 B9.71 B Total liabilities & shareholders' equities 18.22 B17.61 B18.32 B19.35 B19.62 B Total debt 7.61 B7.62 B8 B8.95 B8.95 B Net debt 6.63 B6.52 B7.36 B7.99 B8.31 B

뉴스

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?

Defense Lifts Moat Stocks As Tech Stumbles

로열티 파마, TD Cowen 컨퍼런스에서 전략적 성장 인사이트 발표

Royalty Pharma at TD Cowen Conference: Strategic Growth Insights

Citizens reiterates Zymeworks stock rating on strong cash position

자임워크스, 지헤라 모멘텀으로 2025년 매출 176% 급증